mild® removes a major root cause of lumbar spinal stenosis (LSS) to improve back and leg pain.
mild® for Patients
An hour may change everything for patients with lumbar spinal stenosis (LSS). Find out how this minimally invasive, outpatient procedure, which has a safety profile similar to an epidural steroid injection (ESI), may help you stand longer and walk farther with less pain.
Pain, numbness or tingling in legs or buttocks when walking
Relief when sitting or leaning forward
mild® for Healthcare Professionals
Help your LSS patients, even those with comorbidities, by removing a major root cause of their neurogenic claudication. Move to mild® to provide patients with long-term relief using a therapy that has a safety profile equivalent to an ESI, but with lasting results. Learn more about the minimally invasive mild® Procedure’s key benefits, clinical outcomes and how it can be incorporated into your treatment algorithm.
Although chronic low back pain (CLBP) is a common condition affecting millions, a recent study by The Harris Poll indicated that more than a third of CLBP sufferers had never been told by a healthcare provider what caused their pain.*
For patients with lumbar spinal stenosis (#LSS), the minimally invasive Mild Procedure may be the right solution. By debulking the enlarged ligament that contributes to LSS, Mild can help patients achieve lasting relief.
Visit KnowYourBackStory.com at the 🔗 link in bio to learn more about the prevalence of chronic low back pain and treatment options like the Mild Procedure.
*"Mobility Matters" Harris Poll data at the 🔗 link in bio
Vertos Medical is proud to have joined forces with @aspn_painneuro and the National Association of Memoir Writers to develop the Know Your Back Story campaign, a national public health awareness campaign that seeks to help patients suffering from chronic low back pain learn more about their “back stories.”
Know Your Back Story encourages providers to educate their patients on lumbar spinal stenosis (#LSS) and provide awareness around the enlarged ligament that may be causing their pain.
View our latest blog to learn more about the campaign at the 🔗 link in bio.
According to the “Mobility Matters: Landmark Survey on Chronic Low Back Pain in America” by The Harris Poll, chronic low back pain (CLBP) patients over the age of 50 experience significantly greater difficulty performing physical tasks and making it through the day without pain than their peers without CLBP.*
Visit our recent blog at the 🔗 link in bio to explore more insights from the survey and see how your patients’ functionality may be impacted by CLBP.
*"Mobility Matters" Harris Poll data at the 🔗 link in bio.
We’re proud to highlight Ashley Comer (@acomer3) on her educational Op-Ed article in the Charleston Gazette (@wvgazettemail). As a member of our Advanced Practice Provider (APP) Advisory Board and as a nurse practitioner working within Interventional Pain Management (IPM), Ashley interacts daily with patients suffering from chronic low back pain (CLBP), many of whom are simply searching for relief.
Data from a recent The Harris Poll* survey found that nearly 3 out of every 10 US adults currently suffer from CLBP, and over a third of those surveyed rated their back pain as “severe.” Many of these individuals visited multiple doctors, and while their pain progressed, only then considered seeing an Interventional Pain Specialist.
Read Ashley’s insights at the 🔗 link in bio on why patients should consider IPM at the onset of pain treatment and potential treatment options outside of the often-prescribed opioids.
We’re proud to welcome the newest members of the Vertos team!
Say hello to our VP of Research and Development, Mehrzad Khakpour, District Sales Managers, Angela Pan and Ryan Roberts, District Sales Specialist, Kyle Prewitt, Digital Marketing Manager, Gina Torvik, Marketing Traffic Manager, Karen Heining, and Clinical Specialists, Elizabeth Johnson and Alec Cangelosi.
Interested in joining our team? Click the 🔗 link in bio for employment opportunities.
At last weekend’s @aspn_painneuro Innovation Summit in Las Vegas, Dr. @davedickersonmd presented data from The Harris Poll’s “Mobility Matters: Landmark Survey on Chronic Low Back Pain in America” to demonstrate how people should be moving through the decades of their lives without CLBP.* This survey included the first-ever Mobility Index, introduced as part of the Know Your Back Story campaign. Huge thanks to Dr. Dickerson, a true patient champion!
Learn more about using the Mobility Index to show patients how their mobility measures up at the 🔗 link in bio.
*"Mobility Matters" Harris Poll data at the 🔗 link in bio.
In the News – The Orange County Business Journal (@ocbizjournal) recently featured Vertos Medical and its plan for continued U.S. expansion into 2023.
“We’re growing really, really fast,” Chief Executive Eric Wichems told the Business Journal. “We’re scaling the company and building.”
The article highlights how sales for the Mild Procedure, Vertos Medical’s proprietary treatment for back pain associated with lumbar spinal stenosis (LSS), have doubled in 2021 alone, and growth this year and next will be in the 60% to 70% range.
The company’s goal is to gain a “true national footprint” over the next year to help treat the millions of LSS patients who may benefit from the procedure.
View the article at the 🔗 link in bio and visit www.vertosmed.com for company information and to learn more about the Mild Procedure.
Benyamin RM, Staats PS, MiDAS ENCORE Investigators. mild® is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE Randomized Controlled Trial. Pain Physician. 2016;19(4):229-242.
Mekhail N, Costandi S, Abraham B, Samuel SW. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012;12(6):417-425. doi:10.1111/j.1533-2500.2012.00565.x.
2012 data from Health Market Sciences report for Vertos Medical 2013.
Data on file with Vertos Medical.
Staats PS, Chafin TB, Golvac S, et al. Long-term safety and efficacy of minimally invasive lumbar decompression procedure for the treatment of lumbar spinal stenosis with neurogenic claudication: 2-year results of MiDAS ENCORE. Reg Anesth Pain Med. 2018;43:789-794. doi:10.1097/AAP.0000000000000868.
Based on mild® Procedure data collected in all clinical studies. Major complications are defined as dural tear and blood loss requiring transfusion.
MiDAS ENCORE responder data. On file with Vertos Medical.
Jain S, Deer TR, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manag. 2020;10(5). https://doi.org/10.2217/pmt-2020-0037. Accessed June 1, 2020.
Deer TR, Grider JS, Pope JE, et al. The MIST Guidelines: the Lumbar Spinal Stenosis Consensus Group guidelines for minimally invasive spine treatment. Pain Pract. 2019;19(3)250-274. doi:10.1111/papr.12744.
Hansson T, Suzuki N, Hebelka H, Gaulitz A. The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum. Eur Spine J. 2009;18(5):679-686. doi:10.1007/s00586-009-0919-7.
Treatment options shown are commonly offered once conservative therapies (e.g., physical therapy, pain medications, chiropractic) are not providing adequate relief. This is not intended to be a complete list of all treatments available. Doctors typically recommend treatments based on their safety profile, typically prioritizing low risk/less aggressive procedures before higher risk/more aggressive procedures, but will determine which treatments are appropriate for their patients.
Although the complication rate for the mild® Procedure is low, as with most surgical procedures, serious adverse events, some of which can be fatal, can occur, including heart attack, cardiac arrest (heart stops beating), stroke, and embolism (blood or fat that migrates to the lungs or heart). Other risks include infection and bleeding, spinal cord and nerve injury that can, in rare instances, cause paralysis. This procedure is not for everyone. Physicians should discuss potential risks with patients. For complete information regarding indications for use, warnings, precautions, and methods of use, please reference the devices’Instructions for Use.
Patient stories on this website reflect the results experienced by individuals who have undergone the mild® Procedure. Patients are not compensated for their testimonial. The mild® Procedure is intended to treat lumbar spinal stenosis (LSS) caused by ligamentum flavum hypertrophy. Although patients may experience relief from the procedure, individual results may vary. Individuals may have symptoms persist or evolve or other conditions that require ongoing medication or additional treatments. Please consult with your doctor to determine if this procedure is right for you.
Reimbursement, especially coding, is dynamic and changes every year. Laws and regulations involving reimbursement are also complex and change frequently. Providers are responsible for determining medical necessity and reporting the codes that accurately describe the work that is done and the products and procedures that are furnished to patients. For this reason, Vertos Medical strongly recommends that you consult with your payers, your specialty society, or the AMA CPT regarding coding, coverage and payment.
Vertos Medical cannot guarantee coding, coverage, or payment for products or procedures. View our Billing Guide.
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
Hall S, Bartleson JD, Onofrio BM, Baker HL Jr, Okazaki H, O’Duffy JD. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271-275. doi:10.7326/0003-4819-103-2-271.
Kalichman L, Cole R, Kim DH, et al. Spinal stenosis prevalence & association with symptoms: The Framingham Study. Spine J. 2009;9(7):545-550. doi:10.1016/j.spinee.2009.03.005.
Fukusaki M, Kobayashi I, Hara T, Sumikawa K. Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain. 1998;14(2):148-151. doi:10.1097/00002508-199806000-00010.
Mekhail N, Costandi S, Nageeb G, Ekladios C, Saied O. The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up [published online ahead of print, 2021 May 4]. Pain Pract. 2021;10.1111/papr.13020. doi:10.1111/papr.13020
Friedly JL, Comstock BA, Turner JA, et al. Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.e2. doi:10.1016/j.apmr.2017.02.029
Pope J, Deer TR, Falowski SM. A retrospective, single-center, quantitative analysis of adverse events in patients undergoing spinal stenosis with neurogenic claudication using a novel percutaneous direct lumbar decompression strategy. J Pain Res. 2021;14:1909-1913. doi: 10.2147/JPR.S304997
Pryzbylkowski P, Bux A, Chandwani K, et al. Minimally invasive direct decompression for lumbar spinal stenosis: impact of multiple prior epidural steroid injections [published online ahead of print, 2021 Aug 4]. Pain Manag. 2021;10.2217/pmt-2021-0056. doi:10.2217/pmt-2021-0056
Abstract presented at: American Society of Pain and Neuroscience Annual Conference; July 22-25, 2021; Miami Beach, FL.
Mobility Matters: Low Back Pain in America, Harris Poll Survey, 2022. View data and full summary at knowyourbackstory.com.